C

CASI Pharmaceuticals Inc
NASDAQ:CASI

Watchlist Manager
CASI Pharmaceuticals Inc
NASDAQ:CASI
Watchlist
Price: 5.75 USD 3.6%
Market Cap: 77.1m USD
Have any thoughts about
CASI Pharmaceuticals Inc?
Write Note

CASI Pharmaceuticals Inc
Long-Term Investments

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CASI Pharmaceuticals Inc
Long-Term Investments Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Long-Term Investments Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Investments CAGR 3Y CAGR 5Y CAGR 10Y
C
CASI Pharmaceuticals Inc
NASDAQ:CASI
Long-Term Investments
$1.7m
CAGR 3-Years
-61%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Long-Term Investments
$267m
CAGR 3-Years
-1%
CAGR 5-Years
15%
CAGR 10-Years
8%
Gilead Sciences Inc
NASDAQ:GILD
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Long-Term Investments
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Long-Term Investments
$4.7B
CAGR 3-Years
407%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Long-Term Investments
$8.5B
CAGR 3-Years
14%
CAGR 5-Years
22%
CAGR 10-Years
34%

See Also

What is CASI Pharmaceuticals Inc's Long-Term Investments?
Long-Term Investments
1.7m USD

Based on the financial report for Dec 31, 2023, CASI Pharmaceuticals Inc's Long-Term Investments amounts to 1.7m USD.

What is CASI Pharmaceuticals Inc's Long-Term Investments growth rate?
Long-Term Investments CAGR 3Y
-61%

Over the last year, the Long-Term Investments growth was -62%. The average annual Long-Term Investments growth rates for CASI Pharmaceuticals Inc have been -61% over the past three years .

Back to Top